FLDT(SH:600228)2015-04-27 16:00Financial Performance - Operating revenue rose by 10.73% to CNY 152,642,494.60 from CNY 137,847,742.76 in the same period last year[7] - Net profit attributable to shareholders of the listed company improved to a loss of CNY 1,870,969.10, compared to a loss of CNY 9,334,346.07 in the previous year[7] - Basic and diluted earnings per share were both -0.021 CNY, an improvement from -0.052 CNY in the previous year[7] - Net loss for Q1 2015 was CNY 4,942,472.12, compared to a net loss of CNY 14,517,745.49 in Q1 2014, indicating an improvement[28] - The company's operating revenue for the current period is CNY 3,934,700.50, a decrease of 3.4% compared to CNY 4,072,857.66 in the previous period[30] - Operating profit for the current period is -CNY 2,446,021.27, an improvement from -CNY 7,168,363.10 in the previous period[30] - The net profit for the current period is -CNY 3,758,435.05, showing a reduction in losses compared to -CNY 8,592,477.01 in the previous period[30] - The total comprehensive income for the current period is -CNY 3,758,435.05, compared to -CNY 8,592,477.01 in the previous period, indicating a positive trend[30] Cash Flow and Liquidity - Cash flow from operating activities reached CNY 37,323,291.09, a significant recovery from a negative cash flow of CNY -2,954,134.87 in the same period last year[7] - The net cash flow from operating activities was ¥37,323,291.09, a significant recovery from a negative cash flow of -¥2,954,134.87 in the previous period[15] - Cash and cash equivalents increased by 81.61% to ¥59,713,845.30 from ¥32,880,307.79 due to increased sales recovery funds[15] - Cash and cash equivalents at the end of the period amount to CNY 59,713,845.30, an increase from CNY 56,986,998.02 in the previous period[32] - The company incurred financial expenses of CNY 1,812,194.98, down from CNY 5,681,050.91 in the previous period, indicating cost control efforts[30] - The company has a cash flow from financing activities net amount of -CNY 4,900,081.48, a decline from CNY 24,831,399.96 in the previous period, suggesting reduced financing activities[32] Assets and Liabilities - Total assets increased by 2.62% to CNY 638,352,773.06 compared to the end of the previous year[7] - The total assets as of March 31, 2015, were CNY 264,404,471.93, slightly down from CNY 266,848,298.01 at the beginning of the year[24] - Total liabilities as of March 31, 2015, were CNY 240,905,785.66, compared to CNY 239,591,176.69 at the beginning of the year[24] - The company's total equity attributable to shareholders was CNY 23,498,686.27, down from CNY 27,257,121.32 at the beginning of the year[25] Shareholder Information - The total number of shareholders at the end of the reporting period was 28,204[12] - The largest shareholder, Jiangxi Changjiu Chemical Group Co., Ltd., holds 18.22% of the shares, totaling 43,980,000 shares[12] Operational Efficiency - The company reported a significant increase in cash flow from operating activities, indicating improved operational efficiency[7] - Sales expenses increased by 83.54% to ¥7,377,600.06 from ¥4,019,537.68 due to higher shipping costs[15] - Management expenses rose by 38.84% to ¥6,506,807.70 from ¥4,686,561.42 due to performance compensation accruals[15] - The company paid CNY 102,075,746.87 for goods and services, a decrease from CNY 137,466,191.94 in the previous period, reflecting improved efficiency[31] Future Plans - The company plans to enhance the operational capacity of its subsidiary Changjiu Agricultural Science, focusing on the acrylamide industry[16] - The company has approved the purchase of 60 acres of industrial land to establish a new product R&D and production base[16] Non-Recurring Items - Non-recurring gains and losses totaled -3,231,502.50 CNY for the period[11]